[1] WHO Recommendations: Policy of Interventionist Versus Expectant Management of Severe Pre-eclampsia Before Term[M].Geneva: World Health Organization, 2018:7.
[2] ACOG Practice Bulletin No.202: Gestational hypertension and preeclampsia[J].Obstet Gynecol,2019,133(1):e1-e25
[3] Al-Jameil N, Khan FA, Khan MF, et al. A brief overview of preeclampsia[J]. J Clin Med Res, 2014, 6(1):1-7.
[4] Palomaki GE, Haddow JE, Haddow HRM, et al. Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia[J]. Prenat Diagn, 2015, 35(4):386-393.
[5] Baltajian K, Bajracharya S, Salahuddin S, et al. Sequential plasma angiogenic factors levels in women with suspected preeclampsia[J]. Am J Obstet Gynecol, 2016,215(1):89.e1-e10.
[6] Ren YF, Jiang YJ, Zhang XL, et al. Effects of SHH signaling pathway on trophoblast apoptosis and invasion in preeclampsia patients and its mechanism[J]. Journal of Jilin University (Medicine Edition), 2018, 271(3):56-61.(in Chinese)
任艳芳, 姜永杰, 张秀玲, 等. SHH信号通路对子痫前期患者滋养细胞凋亡和侵袭的影响及其机制[J]. 吉林大学学报(医学版), 2018, 271(3):56-61.
[7] His W. Reni-angiotensin-aldosterone system in the pathogenesis of pregnancy-induced hypertension[J]. Exp Clin Endocrinol Diabetes, 2018, 126(6):362-366.
[8] Eugenia MG, Blood AB, Sands LD, et al. A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity[J]. Am J Physiol Endocrinol Metab, 2018, 315(1):E52-E62.
[9] González-Garrido JA, García-Sánchez JR, Tovar-Rodríguez JM, et al. Preeclampsia is associate with ACE I/D polymorphism obesity and oxidative damage in Mexican women[J].Pregnancy Hypertens, 2017,10:22-27.
[10] Elliot MG. Oxidative stress and the evolutionary origins of preeclampsia[J]. J Reprod Immunol, 2016,114(4):75-80.
[11] Zhou X, Zhang P, Liang T, et al. Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis and coronary heart disease[J]. Heart Vessels, 2020, 35(2):153-161.
[12] González-Garrido José A, García-Sánchez José R, Tovar-Rodríguez José M, et al. Preeclampsia is associate with, ACE, I/D polymorphism, obesity and oxidative damage in Mexican Women[J]. Pregnancy Hypertension, 2017,10:22-27
[13] Xiang ZhH, Jiang XD, Zhang Y, et al. Significance of detecting angiotensin-converting enzyme in predicting pregnancy-induced hypertension syndrome in the second trimester of pregnancy[J].Labeled Immunoassays and Clinical Medicine, 2018, 25(9): 17-19. (in Chinese)
项舟弘,蒋秀娣,张杨,等.孕中期检测血管紧张素转化酶对预测妊娠高血压综合征的意义[J].标记免疫分析与临床, 2018, 25(9):17-19
[14] Al-Jameil N, Khan FA, Khan MF, et al. A brief overview of preeclampsia[J]. J Clin Med Res, 2014, 6(1):1-7.
[15] Jim B, Karumanchi SA. Preeclampsia: pathogenesis, prevention, and long-term complications[J]. Semin Nephrol, 2017, 37(4):386-397.
[16] Gan B, Yang YY, Li M, et al. Analysis of risk factors for preeclampsia[J]. Chinese Journal of Obstetrics and Gynecology, 2013(6): 540-542.(in Chinese)
甘冰, 杨燕嫣, 李敏,等.子痫前期发病危险因素分析[J]. 中国妇产科临床杂志, 2013(6):540-542.
[17] Sibai B. Diagnosis and management of atypical preeclampsia-eclampsia[J]. Am J Obstet Gynecol, 2009, 200(5):481.e1-e7.
[18] Sheng N, Song WQ. Progress in the risk factors of preeclampsia in hypertensive pregnancy[J]. World Medical Information Digest, 2019, 19(27): 51-75.(in Chinese)
胜楠, 宋伟奇. 妊娠高血压子痫前期发病危险因素研究进展[J]. 世界最新医学信息文摘, 2019, 19(27):51-75.
[19] Staff AC, Benton SJ, von Dadelszen P, et al. Redefining preeclampsia using placenta-derived biomarkers[J].Hypertension,2013,61(5):932-942.
[20] Spiel M, Salahuddin S, Pernicone E, et al. Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes[J]. Placenta, 2017, 52:10-16.
|